Literature DB >> 19692470

Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus.

Samuel K Lai1, Kaoru Hida, Shetha Shukair, Ying-Ying Wang, Anna Figueiredo, Richard Cone, Thomas J Hope, Justin Hanes.   

Abstract

To reliably infect a primate model for human immunodeficiency virus (HIV), approximately 10,000-fold more virus must be delivered vaginally than intravenously. However, the vaginal mechanisms that help protect against HIV are poorly understood. Here, we report that human cervicovaginal mucus (CVM), obtained from donors with normal lactobacillus-dominated vaginal flora, efficiently traps HIV, causing it to diffuse more than 1,000-fold more slowly than it does in water. Lactobacilli acidify CVM to pH approximately 4 by continuously producing lactic acid. At this acidic pH, we found that lactic acid, but not HCl, abolished the negative surface charge on HIV without lysing the virus membrane. In contrast, in CVM neutralized to pH 6 to 7, as occurs when semen temporarily neutralizes the vagina, HIV maintained its native surface charge and diffused only 15-fold more slowly than it would in water. Thus, methods that can maintain both a high lactic acid content and acidity for CVM during coitus may contribute to both vaginal and penile protection by trapping HIV before it can reach target cells. Our results reveal that CVM likely plays an important but currently unappreciated role in decreasing the rate of HIV sexual transmission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692470      PMCID: PMC2772788          DOI: 10.1128/JVI.01899-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Target cells in vaginal HIV transmission.

Authors:  Christopher J Miller; Robin J Shattock
Journal:  Microbes Infect       Date:  2003-01       Impact factor: 2.700

2.  A self-sampling method to obtain large volumes of undiluted cervicovaginal secretions.

Authors:  Elizabeth R Boskey; Thomas R Moench; Paul S Hees; Richard A Cone
Journal:  Sex Transm Dis       Date:  2003-02       Impact factor: 2.830

Review 3.  Inhibiting sexual transmission of HIV-1 infection.

Authors:  Robin J Shattock; John P Moore
Journal:  Nat Rev Microbiol       Date:  2003-10       Impact factor: 60.633

4.  Determinants of HIV-1 shedding in the genital tract of women.

Authors:  A Kovacs; S S Wasserman; D Burns; D J Wright; J Cohn; A Landay; K Weber; M Cohen; A Levine; H Minkoff; P Miotti; J Palefsky; M Young; P Reichelderfer
Journal:  Lancet       Date:  2001-11-10       Impact factor: 79.321

Review 5.  Potential role of lactobacilli as prophylactic agents against genital pathogens.

Authors:  C Barbés; S Boris
Journal:  AIDS Patient Care STDS       Date:  1999-12       Impact factor: 5.078

6.  Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers.

Authors:  H Hocini; P Becquart; H Bouhlal; H Adle-Biassette; M D Kazatchkine; L Bélec
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

7.  Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells.

Authors:  J Hu; M B Gardner; C J Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 8.  Recent observations on HIV type-1 infection in the genital tract of men and women.

Authors:  Robert W Coombs; Patricia S Reichelderfer; Alan L Landay
Journal:  AIDS       Date:  2003-03-07       Impact factor: 4.177

9.  Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis.

Authors:  Stuart S Olmsted; Leslie A Meyn; Lisa C Rohan; Sharon L Hillier
Journal:  Sex Transm Dis       Date:  2003-03       Impact factor: 2.830

10.  Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

Authors:  Ronald S Veazey; Robin J Shattock; Melissa Pope; J Christian Kirijan; Jennifer Jones; Qinxue Hu; Tom Ketas; Preston A Marx; Per Johan Klasse; Dennis R Burton; John P Moore
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

View more
  119 in total

Review 1.  Strategies for eliciting HIV-1 inhibitory antibodies.

Authors:  Georgia D Tomaras; Barton F Haynes
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

Review 2.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

3.  Vaginal microbiome of reproductive-age women.

Authors:  Jacques Ravel; Pawel Gajer; Zaid Abdo; G Maria Schneider; Sara S K Koenig; Stacey L McCulle; Shara Karlebach; Reshma Gorle; Jennifer Russell; Carol O Tacket; Rebecca M Brotman; Catherine C Davis; Kevin Ault; Ligia Peralta; Larry J Forney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

4.  Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation.

Authors:  Fangda Xu; Michael Reiser; Xinwei Yu; Suryaram Gummuluru; Lee Wetzler; Björn M Reinhard
Journal:  ACS Nano       Date:  2016-01-06       Impact factor: 15.881

Review 5.  Maternal Microbiome and Pregnancy Outcomes That Impact Infant Health: A Review.

Authors:  Anne L Dunlop; Jennifer G Mulle; Erin P Ferranti; Sara Edwards; Alexis B Dunn; Elizabeth J Corwin
Journal:  Adv Neonatal Care       Date:  2015-12       Impact factor: 1.968

Review 6.  HIV vaccines: lessons learned and the way forward.

Authors:  Jerome H Kim; Supachai Rerks-Ngarm; Jean-Louis Excler; Nelson L Michael
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

7.  Nanoparticle-based flow virometry for the analysis of individual virions.

Authors:  Anush Arakelyan; Wendy Fitzgerald; Leonid Margolis; Jean-Charles Grivel
Journal:  J Clin Invest       Date:  2013-08-08       Impact factor: 14.808

8.  Thermosensitive and mucoadhesive pluronic-hydroxypropylmethylcellulose hydrogel containing the mini-CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervicovaginal mucus.

Authors:  Kawthar Bouchemal; Armelle Aka-Any-Grah; Nathalie Dereuddre-Bosquet; Loïc Martin; Vanessa Lievin-Le-Moal; Roger Le Grand; Valérie Nicolas; Davide Gibellini; David Lembo; Christian Poüs; Armand Koffi; Gilles Ponchel
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

9.  Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses.

Authors:  Samuel K Lai; Ying-Ying Wang; Kaoru Hida; Richard Cone; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

10.  Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees.

Authors:  Pinghuang Liu; Nicole L Yates; Xiaoying Shen; Mattia Bonsignori; M Anthony Moody; Hua-Xin Liao; Youyi Fong; S Munir Alam; R Glenn Overman; Thomas Denny; Guido Ferrari; Christina Ochsenbauer; John C Kappes; Victoria R Polonis; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; David C Montefiori; Peter Gilbert; Nelson L Michael; Jerome H Kim; Barton F Haynes; Georgia D Tomaras
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.